Connection

James Ballenger to Receptor, Cholecystokinin B

Back to Details
This is a "connection" page, showing publications James Ballenger has written about Receptor, Cholecystokinin B.
James Ballenger
Connection Strength
0.008
Receptor, Cholecystokinin B
  1. A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder. Biol Psychiatry. 1995 Apr 01; 37(7):462-6.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.